Etanercept 50mg Vial
- Brand Names: Enbrel (originator); biosimilars: Benepali, Brenzys, Erelzi
- Form: Vial, Solution for subcutaneous injection
- Strength: 50 mg
- Manufacturer: Amgen; outside US/Pfizer; Biosimilar manufacturers
- Country: India/USA/EU
- MOQ: 10 Units
- Shelf Life: 24 Months
- Storage: 2–8 °C, protect from light
Description
Indications & Usage: Etanercept is indicated for moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and moderate to severe plaque psoriasis. Mechanism: a TNF‑alpha decoy receptor fusion protein that binds & neutralizes soluble TNF
